| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 4, 2019 | ELAN Elanco Animal Health Inc | Simmons Jeffrey N52 | President, CEO &Director | Buy | 75,750 | $26.55 | $2,011,162.50 | +19.2% | |
| Sep 4, 2019 | ORGO Organogenesis Holdings Inc. | Katz Michael W | 10% Owner | Buy | 10,000 | $4.50 | $44,975.00 | New | |
| Sep 4, 2019 | LNTH Lantheus Holdings, Inc. | Duffy Michael P | SVP And General Counsel | Sell | 5,604 | $20.60 | $115,464.82 | -3.9% | |
| Sep 4, 2019 | ORGO Organogenesis Holdings Inc. | MacKie Wayne D | Director | Buy | 82,000 | $4.47 | $366,210.60 | +164.0% | |
| Sep 3, 2019 | LNTH Lantheus Holdings, Inc. | Heino Mary Anne50 | President &CEO | Sell | 25,538 | $21.21 | $541,678.86 | -4.1% | |
| Sep 3, 2019 | ORGO Organogenesis Holdings Inc. | Leibowitz Arthur S | Director | Buy | 5,000 | $4.20 | $21,000.00 | New | |
| Sep 3, 2019 | LLY Eli Lilly & Co | Zulueta Alfonso G | SVP &President, Lilly Int'l | Sell | 19,500 | $112.91 | $2,201,745.00 | -33.7% | |
| Sep 3, 2019 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 6,736 | $100.00 | $673,600.00 | -25.1% | |
| Sep 3, 2019 | AMRN Amarin Corp Plc\uk | Ekman Lars73 | Director | Sell | 91,016 | $15.01 | $1,365,722.38 | -100% | |
| Aug 30, 2019 | PAHC Phibro Animal Health Corp | Corcoran E Thomas61 | Director | Buy | 5,000 | $21.21 | $106,050.00 | +50.0% | |
| Aug 30, 2019 | IRWD Ironwood Pharmaceuticals Inc | McCourt Thomas A66 | President | Sell | 220,000 | $9.24 | $2,032,800.00 | -66.7% | |
| Aug 30, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 3,100 | $5.16 | $16,003.00 | -1.8% | |
| Aug 29, 2019 | COLL Collegium Pharmaceutical, Inc | Hirsch David | Director | Sell | 22,106 | $11.65 | $257,534.90 | -34.4% | |
| Aug 28, 2019 | ANIK Anika Therapeutics, Inc. | Larsen Glenn R. | Director | Sell | 4,355 | $57.21 | $249,149.55 | -36.5% | |
| Aug 28, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Nark Ted C | Director | Buy | 50,000 | $2.39 | $119,500.00 | +818.7% | |
| Aug 27, 2019 | AQST Aquestive Therapeutics, Inc. | Barber Daniel77 | Svp-chief Operating Officer | Buy | 2,000 | $3.99 | $7,980.00 | +2.0% | |
| Aug 27, 2019 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 3,264 | $100.05 | $326,554.92 | -7.6% | |
| Aug 26, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 7,500 | $22.59 | $169,420.42 | -8.7% | |
| Aug 26, 2019 | TLPH Talphera, Inc. | Edwards Mark G | Director | Buy | 15,000 | $2.19 | $32,805.50 | +3.6% | |
| Aug 23, 2019 | TXMD Therapeuticsmd, Inc. | Russell Angus C. | Director | Buy | 10,000 | $2.77 | $27,700.00 | +12.0% | |
| Aug 23, 2019 | SUPN Supernus Pharmaceuticals, Inc. | Khattar Jack A.64 | President, CEO | Buy | 7,200 | $26.39 | $189,982.08 | +1.6% | |
| Aug 23, 2019 | SIGA Siga Technologies Inc | Savas Paul G | Director | Buy | 10,000 | $4.95 | $49,500.00 | +3.8% | |
| Aug 23, 2019 | BTAI Bioxcel Therapeutics, Inc. | Mueller Peter | Director | Buy | 1,554 | $9.34 | $14,514.36 | +0.9% | |
| Aug 22, 2019 | ELAN Elanco Animal Health Inc | Hicks Michael-Bryant | See Remarks | Buy | 11,030 | $26.65 | $293,905.38 | +48.2% | |
| Aug 22, 2019 | PRGO Perrigo Co Plc | Winowiecki Ronald | CFO | Sell | 826 | $48.03 | $39,673.61 | -10.6% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.